In recent years, an unprecedented level of interest in the promise of psychedelics has taken hold. In the United States, many types of psychedelics are being investigated for use in treating an array of mental health conditions. The U.S. nonprofit Multidisciplinary Association for Psychedelic Studies (MAPS) has announced promising phase 3 clinical trial results for […]
COVID-19 greatly accelerated the adoption of telehealth, and now three years later, states are exploring new policies to expand or streamline the state licensure process for physicians while ensuring continued authority to regulate and oversee the practice of medicine. In a new webinar, American Medical Association (AMA) President Jesse M. Ehrenfeld, MD, MPH will moderate a panel […]
The Mental Health Parity and Addiction Equity Act (MHPAEA) requires health plans to provide mental health benefits, including coverage for substance use disorders (SUDs), that are in “parity” with medical and surgical benefits. The exploding opioid and SUD crisis coupled with the soaring rates of mental health conditions post-COVID have put mental health parity in […]
From the end of the COVID-19 public health emergency (PHE) to the overturning of Roe v. Wade to the skyrocketing growth of virtual care, multiple forces are converging to remap the health care landscape. In a new webinar, Manatt Health will draw on the deep-dive legal, policy and market analyses in its Manatt on Health premium information service to […]
Over the past few years, there has been tightening enforcement and numerous lawsuits driven by the increasingly complex web of federal and state anti-kickback and anti-inducement statutes. In a new CLE-eligible webinar, Manatt Health will guide plans and providers through the emerging landscape of fraudulent health care schemes—and provide practical answers to the legal questions […]
The inclusion of racial and ethnic groups in clinical trials has been a national priority for decades, but progress toward that goal has been limited. When the COVID-19 pandemic threw into stark relief the underlying inequities in health care access (and therefore in clinical trial access), Congress and the Administration were moved to action. In […]
Individuals leaving incarceration have disproportionately higher rates of physical and behavioral health diagnoses and are at higher risk for injury and death compared with people who have not been incarcerated. Race disparities in incarceration further exacerbate health inequities for people of color upon release. Justice-involved individuals often will be released into the community with no […]
Tuesday, July 181:00 p.m.–2:00 p.m. ET Of the $2.2 billion in False Claims Act (FCA) settlements and judgments that the Department of Justice (DOJ) reported in fiscal year 2022, $1.7 billion related to matters involving the health care industry. That staggering number reflects only federal losses, with the DOJ recovering additional amounts for state Medicaid […]
Useful innovations—particularly those that reduce costs—often fail to take root and spread in the health sector while others of sometimes dubious value proliferate. The first webinar in our innovation series will discuss why valuable innovations sometimes go missing in health care and what to do about it. Key topics include: The economics of innovation in […]
From artificial intelligence to telemedicine to gene therapies, health care is experiencing a revolution in technology and innovation. But technology is not destiny. People choose when and how to use the new tools. The second webinar in our innovation series will discuss how to get the most out of transformative technological change in healthcare. Key […]
